Anti-inflammatory Ellagitannins from Cleidion brevipetiolatum for the Treatment of Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Anti-inflammatory Ellagitannins from Cleidion brevipetiolatum for the Treatment of Rheumatoid Arthritis

Published:2019-08-16 Issue:9 Volume:82 Page:2409-2418
ISSN:0163-3864
Container-title:Journal of Natural Products
language:en
Short-container-title:J. Nat. Prod.

Author:

Zhao Min¹,Yuan Xue¹,Pei Ying-He¹,Ye Hao-Yu¹,Peng Ai-Hua¹,Tang Ming-Hai¹,Guo Da-Le²,Deng Yun²,Chen Li-Juan¹²^ORCID

Affiliation:

1. Laboratory of Natural Product Drugs, State Key Laboratory of Biotherapy and Cancer Center, West China Medical School, West China Hospital, Sichuan University, Chengdu 610041, People’s Republic of China

2. The Ministry of Education Key Laboratory of Standardization of Chinese Herbal Medicine, State Key Laboratory, Breeding Base of Systematic Research Development and Utilization of Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, People’s Republic of China

Funder

National Natural Science Foundation of China

West China Hospital, Sichuan University

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,Analytical Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jnatprod.8b00984

Reference44 articles.

1. Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis

2. Is rheumatoid arthritis disappearing?